Summary Basal cell carcinomas (BCCs) are very frequent cutaneous cancers, often located on the face. Cure rates with surgery and radiotherapy are high, but these treatments have never been compared prospectively. A randomized trial was initiated in 1982 to compare surgery and radiotherapy in the treatment of primary BCC of the face measuring less than 4 cm. The primary end point was the failure rate (persistent or recurrent disease) after 4 years of follow-up. The secondary end point was the cosmetic results assessed by the patient, the dermatologist and three persons not involved in the trial. In the course of the trial, 347 patients were treated. Of the 174 patients in the surgery group, 71% had local anaesthesia and 91% frozen section examination. Of the 173 patients in the radiotherapy group, 55% were treated with interstitial brachytherapy, 33% with contactherapy and 12% with conventional radiotherapy. The 4-year actuarial failure rate (95% Cl) was 0.7% (0.1-3.9%) in the surgery group compared with 7.5% (4.2-13.1%) in the radiotherapy group (log-rank P= 0.003). The cosmetic results assessed by four of the five judges were significantly better after surgery than after radiotherapy. Eighty-seven per cent of the surgery-treated patients and 69% of the radiation-treated patients considered the cosmetic result as good (P < 0.01). Thus, in the treatment of BCC of the face of less than 4 cm in diameter, surgery should be preferred to radiotherapy.
Basal cell carcinomas (BCCs) are the most frequent cutaneous cancers among white people, accounting for over 70% of all cases (Coebergh et al, 1991; Ko et al, 1994) . Several studies have shown a recent increase in incidence (Fears and Scotto 1982; Levi et al, 1988; Gallagher et al, 1990; Coebergh et al, 1991; Ko et al, 1994) . The head and neck are the most affected sites, accounting for around 70% of all cases (Levi et al, 1988; Gallagher et al, 1990; Coebergh et al, 1991) . Several therapeutic modalities are used to treat this neoplasm: radiotherapy, excisional surgery, Mohs surgery, electrodesiccation with curettage and cryosurgery. The choice of the treatment technique is contingent on various factors, such as tumour characteristics, the general condition of the patient, cosmetic considerations, skill and the preference of the physicians. Surgical excision and radiation therapy are commonly used for treatment of primary BCC (Fleming et al, 1995 ; Committee on Guidelines of Care and Task Force on Basal Cell Carcinoma, 1992) . These methods achieve cure rates of between 90% and 98% (Rowe et al, 1989; Silverman et al, 1991; Goldberg 1996) but have never been compared prospectively (Preston and Stern 1992; Fleming et al, 1995; Goldberg 1996) . Surgery is more commonly used than radiotherapy, but in some regions of the face (eyelids, nose, ear) radiotherapy has been recommended because of cosmetic reasons.
In 1982, a prospective, randomized trial was initiated at the Gustave Roussy Institute to compare surgery and radiotherapy in the treatment of primary BCC of the face. The main end point was the cure rate after 4 years of follow-up; the secondary end point was cosmetic results.
PATIENTS AND METHODS Eligibility and study design
The criterion for inclusion was the presence of a previously untreated BCC of the face, confirmed by biopsy, with the largest diameter below 4 cm. Further eligibility criteria included no contraindication to surgery and radiotherapy, and informed consent. Patients with BCC located on the scalp or the neck, patients who had total removal of BCC at biopsy, patients with five or more BCCs and patients with a life expectancy of below 3 years were not eligible.
Treatment methods
Patients were randomly allocated to surgery or radiotherapy by means of sequential sealed envelopes opened by the trial data manager. In case of multiple primary BCCs, the largest tumour was assigned to the trial and the others were treated with the same technique.
Surgery
Surgical treatment consisted in the resection of the whole tumour with a free margin of at least 2 mm from the visible borders. [65] [66] [67] [68] [69] [70] Gy was delivered at the reference isodose, according to the Paris dosimetry method (Dutreix et al, 1987) , over a period of 5-7 days. The patient was hospitalized throughout treatment.
Superficial contactherapy (50 kV) Follow-up Follow-up consultations were planned at 3, 6 and 12 months after the end of treatment and thereafter yearly until the fourth year. Patients were examined by a dermatologist and photographs of the scar were taken at three standardized distances.
Assessment criteria
As BCC is not a life-threatening neoplasm, the main end point was the rate of histologically confirmed persistent tumour or recurrence after 4 years of follow-up (failure rate). The second assessment criterion was the cosmetic result. Just before each follow-up visit and in the absence of all physicians implicated, the patient noted his or her level of satisfaction on a 10-cm visual analogue scale going from 'not satisfied' to 'satisfied'. In addition, the dermatologist questioned the patient about the cosmetic result (good, fair or bad) during each follow-up examination. The dermatologist noted how the scar appeared (slightly visible, clearly marked or bad). The cosmetic result was also independently assessed, from the photographs taken at each follow-up visit, by three persons not involved in the trial (the photographer, a data manager and a medical secretary) and blinded to the treatment. They could choose between good, fair or bad cosmetic result.
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Required number of patients Kempton, 1994) (Kaplan and Meier, 1958) and their 95% confidence interthe following reasons. In the surgery group, two decided to be vals (95% CI) were calculated with the Rothman (1978) method. treated elsewhere, three refused treatment and one had seborrhoeic The failure-free interval started from the date of randomization keratosis. In the radiotherapy group, one patient decided to be to the date of histologically confirmed recurrent or persistent carcitreated elsewhere and six refused treatment. The results presented noma. Patients who died during the trial were censored at the date here thus concern 347 patients who were analysed within their of death. Patients lost to follow-up were censored at the date of the allocated treatment group. In each group, one patient refused the last examination. The failure curves were compared with the logallocated treatment and was treated by the other method. rank test (Peto et al, 1977) . Cox's model (Cox, 1972) were similar in the two groups. The mean of the largest diameter was 11.1 mm (s.d. = 5.7) in the surgical group and 11.7 mm (s.d. = 5.7) in the radiotherapy group. Only 7% of patients had a BCC with the largest diameter exceeding 20 mm. Sites of treated BCC were similar in the two groups.
Treatments Among the 174 patients in the surgery group, one was treated by conventional radiotherapy. Resection was performed under local anaesthesia for 123 patients (71%). Frozen section examination was performed in 158 cases (91%) and showed that additional resection was necessary before closure in 67 cases (39%) (lateral additional resection in 46 cases, depth resection in 11 cases and both in ten cases). Wound closure was obtained using direct sutures (48%) or flaps (46%). Nine patients (5%) had grafts, and wounds healed spontaneously in two (1%). After definitive pathological diagnosis, excision was considered complete in 160 cases (92%), borderline (i.e. frozen section was free of disease but embedded section was involved) in six cases (3%) and incomplete in seven cases (5%), six of which underwent further resection. Failure rate Only one patient had a recurrence in the surgery group, whereas 11 patients had either further progression of the tumour (three patients) or recurrence (eight patients) in the radiotherapy group. The failure rate was significantly (log-rank test P = 0.003) lower in the surgery group than in the radiotherapy group (Figure 1) . The 4-year actuarial failure rate (95% CI) was 0.7% (0.1-3.9%) in the surgery group and 7.5% (4.2-13.1%) in the radiotherapy group. After brachytherapy, contactherapy and conventional radiotherapy, the failure rates were 8.8% (4.3-17.1%), 6.6% (2.2-17.8%) and 5% (0.9-23.6%) respectively. With Cox's model, which allowed adjustment for the initial characteristics of the BCC (well-or ill-defined borders, infiltration, size, site), the relative risk of failure between radiotherapy and surgery was still significant (P = 0.001) at 11.7 (95% CI 1.5-91). Table 2 shows the cosmetic appraisal. Cosmetic results were significantly better after surgery than after radiotherapy in the eyes of the patient, the dermatologist, the photographer and the data manager, throughout the period of follow-up. The difference, although not significant, was also in favour of surgery for the British Journal of Cancer (1997) 76(1), [100] [101] [102] [103] [104] [105] [106] tlw Cancer Research Campaign 1997 medical secretary. Cosmetic results were similar in the two groups immediately after treatment, then they improved in the surgical group, and went on to become clearly better after 2 years of follow-up, whereas they deteriorated or remained stable in the radiotherapy group. At 4 years, the patients assessed their cosmetic results as good in 87% after surgery and in 69% after radiotherapy; likewise, the percentages recorded for a slightly visible scar assessed by the dermatologist were 79% and 40% respectively for the two groups. Moreover, the percentage of good cosmetic results was higher after surgery than after radiotherapy for the four most frequent locations of the face (nose; cheek and periauricular area; periocular area; forehead and temple) (Figure 2) .
Cosmetic result
During the first year after surgery, the main characteristics of scars were deformations and constrictions, which tended to decrease during the follow-up period, but continued to affect 25% and 5% of the patients respectively at 4 years. After radiotherapy, dyspigmentations and telangiectasia developed, involving more than 65% of the patients at 4 years. Radiodystrophy concerned 41 % of the patients at 4 years, and 5% of the patients in the radiotherapy group had necrosis that did not occur after contactherapy. Three ophthalmologic complications were observed: one ectropion after surgery and one cataract and one lachrymal duct stenosis after radiotherapy.
DISCUSSION
The present trial showed a significant advantage, in terms of cure rate and also in terms of cosmetic results for primary BCC of the face, for surgery as opposed to radiotherapy. Surgery and radiotherapy were performed by experienced physicians who could choose the most appropriate procedure in each treatment group, according to the individual BCC characteristics. After 4 years of follow-up, the failure rate was 0.7% in the surgical group and 7.5% in the radiotherapy group, and the cosmetic results were assessed as 'good' by 87% and 69% respectively of the patients in the two groups. Several previous studies have reported cure rates and cosmetic results with surgery and radiotherapy but this study is the first randomized trial, thus giving an unbiased comparison of the two treatments. It is also the first study in which cosmetic results were assessed by observers not involved in the trial, in addition to patients and dermatologist.
Failure rate
In our study, the failure rate after surgery was very low (0.7% at 4 years), lower than the published failure rates after surgical resection which range from 2% to 10% (Marchac and Duport, 1980; Dubin and Kopf, 1983; Roenigk et al, 1986; Marchac, 1988; Ashby et al, 1989; Rowe et al, 1989; Silverman et al, 1992a; Bonvallot et al, 1993; Lawrence, 1993) . It is closer to that obtained with Mohs surgery, which is often below 2% (Tromovitch and Stegman, 1978; Robins, 1981; Robins et al, 1985; Roenigk et al, 1986; Rowe et al, 1989; Lawrence, 1993; Hruza, 1994) . In contrast to radiotherapy, a histological appraisal of the efficiency of the treatment is possible with surgery. When an incomplete resection is diagnosed based on the embedded section, additional treatment or vigilant observation should be discussed with each patient, because recurrence occurs in only 25-50% of the cases and further treatment may prove difficult for physical or psychological reasons (Richmond and Davie, 1987; Liu et al, 1991; Preston and Stern, 1992) . The frozen section examination, which assesses immediately the quality of the resection, avoids this problem and allows complete resection with a single surgical procedure in most cases.
Although the failure rate was higher after radiotherapy than surgery, cure was still obtained at 4 years in 92.5% of the cases.
The overall cure rate after X-ray therapy was consistent with published results, which range from 90% to 98% (Nevrkla and Newton, 1974; Orton, 1978 , Reymann, 1980 Dubin and Kopf, 1983; Fitzpatrick et al, 1984; Brady et al, 1987; Petrovich et al, 1987; Ashby et al, 1989; Mazeron et al, 1989; Rowe et al, 1989; Lovett et al, 1990; Wilder et al, 1991; Silverman et al, 1992b) . More relapses occurred with brachytherapy in our study (8.8% failure rate at 4 years) than published in the literature, in which failure rates are less than 5% (Daly et al, 1984; Pierquin et al, 1987; Mazeron et al, 1989; Crook et al, 1990 (Chahbazian and Brown, 1980; Goldsmith and Sherwin, 1983; Brady et al, 1987; Pierquin et al, 1987; Mazeron et al, 1989; Morrison et al, 1993; Fleming et al, 1995) .
Surgical scars were often marked at the initial evaluation but they improved with time. After 4 years, patients were satisfied in 87% of the cases and dermatologists in 79%. This is consistent with the previously published rates of good aesthetic results assessed by patients or physicians, which range from 77% to 93% (Lawrence et al, 1986; Marchac, 1988; Hohmann et al, 1992; Silverman et al, 1992a; Bonvallot et al, 1993) , and the improvement of the results with time confirms the study of Silverman (Silverman et al, 1992a) . The good cosmetic result is partly related to almost systematic recourse to frozen section examination, which allows surgeons to spare healthy skin tissue surrounding the tumour. In our trial, the high rate (42%) of additional excisions based on the results of the frozen section examination suggested that surgery was initially as conservative as possible.
Cutaneous necrosis was present in 5% of the patients treated with radiotherapy. This is in agreement with the rates published, which range from 2% to 5% (Nevrkla and Newton, 1974; Brady et al, 1987; Orton, 1978; Pierquin et al, 1987; Crook et al, 1990; Lovett et al, 1990; Lang and Maize, 1991; Wilder et al, 1991) . The other major residual abnormalities were, as expected, dyspigmentations and telangiectasia. The rate of good cosmetic results appears to be lower than those published, but comparison was difficult because of the wide range of published rates of good aesthetic results (60-93%) assessed by patients or physicians (Chahbazian and Brown, 1980; Goldsmith and Sherwin, 1983; Brady et al, 1987; Pierquin et al, 1987; Mazeron et al, 1989; Crook et al, 1990; Lovett et al, 1990; Silverman et al, 1992b) . The deterioration of the cosmetic appearance with time with radiotherapy confirms the previous results of Silverman (1992b) and the small study of Cooper (1988) . This is the first randomized trial of previously untreated BCC comparing surgery and radiotherapy. Surgery proved to be superior to radiotherapy in treatment efficacy and cosmetic result. Thus, for untreated BCC of the face of less than 4 cm, surgery is recommended as first-line treatment and radiotherapy ought to be reserved for patients in whom surgery is contraindicated.
